Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 3,030.00
-115.00 (-3.66%)
Oct 29, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 39.53 billion as of October 28, 2026. It is the 33,935th most valuable company in the world and the 1,956th biggest in South Korea. Its market cap has decreased by 60.03% in one year.
Market Cap
39.53B
Enterprise Value
23.30B
Revenue
395.50M
Global Rank
Country Rank
#1,956 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 39.53B, a decrease of -62.79%. That is a compound annual growth rate of -41.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 39.53B | -65.69% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam Chun Dang Pharm. | 4.42T |
| PharmaResearch | 2.38T |
| ST Pharm | 1.85T |
| Mezzion Pharma | 1.68T |
| Oscotec | 1.38T |
| DongKook Pharmaceutical | 1.06T |
| Huons Global | 251.48B |
| KOLMAR BNH | 206.27B |